Beam Therapeutics Inc (NASDAQ: BEAM) is -28.89% lower on its value in year-to-date trading and has touched a low of $18.30 and a high of $35.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BEAM stock was last observed hovering at around $19.53 in the last trading session, with the day’s loss setting it -1.89%.
Currently trading at $17.64, the stock is -26.26% and -32.88% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.36 million and changing -9.70% at the moment leaves the stock -31.39% off its SMA200. BEAM registered -46.63% loss for a year compared to 6-month gain of -29.60%. The firm has a 50-day simple moving average (SMA 50) of $26.2726 and a 200-day simple moving average (SMA200) of $25.7044.
The stock witnessed a -29.74% loss in the last 1 month and extending the period to 3 months gives it a -33.68%, and is -24.05% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.95% over the week and 8.81% over the month.
Beam Therapeutics Inc (BEAM) has around 483 employees, a market worth around $1.76B and $63.52M in sales. Profit margin for the company is -593.13%. Distance from 52-week low is -3.63% and -49.97% from its 52-week high. The company has generated returns on investments over the last 12 months (-42.74%).
The EPS is expected to shrink by -3.23% this year.
Beam Therapeutics Inc (BEAM) Top Institutional Holders
336.0 institutions hold shares in Beam Therapeutics Inc (BEAM), with institutional investors hold 80.07% of the company’s shares. The shares outstanding are 99.84M, and float is at 88.04M with Short Float at 13.82%. Institutions hold 79.10% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 7.9 million shares valued at $185.11 million. The investor’s holdings represent 9.6701% of the BEAM Shares outstanding. As of 2024-06-30, the second largest holder is FARALLON CAPITAL MANAGEMENT LLC with 7.91 million shares valued at $185.4 million to account for 9.6135 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 7.63 million shares representing 9.2749% and valued at over $178.87 million, while ARK INVESTMENT MANAGEMENT LLC holds 9.2649 of the shares totaling 7.63 million with a market value of $178.68 million.
Beam Therapeutics Inc (BEAM) Insider Activity
#####
Still, SEC filings show that on Apr 01 ’25, CHRISTINE BELLON (Officer) Proposed Sale 18,125 shares at an average price of $22.21 for $0.4 million. The insider now directly holds shares of Beam Therapeutics Inc (BEAM).
